Tyler Johnson
Impact in
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Cutaneous Melanoma Detection and Management
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 7
- CAR-T cell therapy research 2
- Colorectal Cancer Surgical Treatments 2
-
- Interprofessional Education and Collaboration 2
- Co-authors
- Davendra Sohal (2 shared papers)Philip A. Philip (1 shared paper)Daniel A. Laheru (1 shared paper)Pelin Cinar (1 shared paper)Christopher H. Crane (1 shared paper)Manish A. Shah (1 shared paper)Eileen M. O’Reilly (1 shared paper)Vaibhav Sahai (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)Epilepsy & Behavior (2 papers)BMC Medical Education (2 papers)Neuro-Oncology (1 paper)PLoS ONE (1 paper)
- Partner nations
- United StatesUgandaUnited Kingdom
In The Last Decade
Tyler Johnson
29 papers receiving 453 citations
Peers
Comparison fields: 5 of 70
- Oncology 257
- Cancer Research 96
- Pathology and Forensic Medicine 51
- Internal Medicine 5
- Pulmonary and Respiratory Medicine 45
Countries citing papers authored by Tyler Johnson
This map shows the geographic impact of Tyler Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tyler Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tyler Johnson more than expected).
Fields of papers citing papers by Tyler Johnson
This network shows the impact of papers produced by Tyler Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tyler Johnson. The network helps show where Tyler Johnson may publish in the future.
Co-authors
The 25 scholars most cited alongside Tyler Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 195 | |
| 2 | 2023 | 66 | |
| 3 | NCCN melanoma practice guidelines. National Comprehensive Cancer Network. | 1998 | 62 |
| 4 | 2022 | 25 | |
| 5 | 2014 | 19 | |
| 6 | 2021 | 16 | |
| 7 | 2023 | 9 | |
| 8 | 2021 | 8 | |
| 9 | 2019 | 8 | |
| 10 | 2017 | 7 | |
| 11 | 2023 | 5 | |
| 12 | 2022 | 5 | |
| 13 | 2019 | 5 | |
| 14 | Bruton's tyrosine kinase inhibitors in chronic lymphocytic leukemia and lymphoma. | 2016 | 5 |
| 15 | 2022 | 3 | |
| 16 | 2025 | 3 | |
| 17 | 2023 | 2 | |
| 18 | 2022 | 2 | |
| 19 | 2014 | 2 | |
| 20 | 2024 | 1 |
About Tyler Johnson
Tyler Johnson is a scholar working on Oncology, General Health Professions, Public Health, Environmental and Occupational Health, Psychiatry and Mental health and Surgery, having authored 31 papers that have together received 457 indexed citations. Recurring topics across this work include Interprofessional Education and Collaboration (2 papers), CAR-T cell therapy research (2 papers), Advances in Oncology and Radiotherapy (2 papers), Economic and Financial Impacts of Cancer (2 papers), Epilepsy research and treatment (2 papers), Colorectal Cancer Surgical Treatments (2 papers), Chronic Lymphocytic Leukemia Research (1 paper) and Hemophilia Treatment and Research (1 paper). The work is most often cited by research in Oncology (257 citations), Cancer Research (96 citations), Pathology and Forensic Medicine (51 citations), Internal Medicine (5 citations) and Pulmonary and Respiratory Medicine (45 citations). Tyler Johnson has collaborated with scholars based in United States, Uganda and United Kingdom. Frequent co-authors include Davendra Sohal, Philip A. Philip, Daniel A. Laheru, Pelin Cinar, Christopher H. Crane, Manish A. Shah, Eileen M. O’Reilly, Vaibhav Sahai, Shubham Pant and Mehmet Sitki Copur. Their work appears in journals such as Journal of Clinical Oncology, Epilepsy & Behavior, BMC Medical Education, Neuro-Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.